Editors, authors and reviewers should follow the best-practice guidelines on ethical behavior and ICMJE’s Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. https://lnkd.in/eEShc4yf #cancer #research #science #OA #ebm
Oncotarget
Book and Periodical Publishing
Orchard Park, NY 786 followers
Oncotarget is a peer-reviewed, open-access biomedical journal covering research on all aspects of oncology
About us
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is indexed by MEDLINE/PubMed and PMC/PubMed. Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
- Website
-
http://www.oncotarget.com
External link for Oncotarget
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Orchard Park, NY
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Oncology, Cancer, Tumor, Cancer Research, Open Access Publishing, Science, Hematology Oncology, Journal Publication, and Peer-Review
Locations
-
Primary
6666 East Quaker Street
1A
Orchard Park, NY 14127, US
Employees at Oncotarget
-
Wafik S. El-Deiry, MD, PhD, FACP
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RI
-
Vanessa Petry H. Bragaia
Médica oncologista clínica do ICESP e OncologiaDor Hospital Assunção e Central Clinic Santo André
-
Bruno R. B. Pires, Ph.D.
PhD in Oncology | Professor | Scientist | Cancer researcher | Science Writer | Peer Reviewer | Grant referee
-
Mauro Podda
Lecturer in Surgery and Honorary Consultant Surgeon presso Università degli Studi di Cagliari
Updates
-
Listen to an #audio recording of a #pressrelease about this #editorial: "DDX41 and its unique contribution to myeloid leukemogenesis." https://lnkd.in/eTs6ke3W #leukemia #aml #paperspotlight #soundcloud #podcast #meded #publishing #openaccess
DDX41's Unique Contribution to Myeloid Leukemogenesis
soundcloud.com
-
Watch an #oncotargetshort #video about this #editorial from Volume 15: "DDX41 and its unique contribution to myeloid leukemogenesis." https://lnkd.in/eMKQ3wfx #cancer #paperspotlight #AML #leukemia #neoplasms #openaccess #publishing #peerreviewed #journal #meded #research
-
#PaperSpotlight: On July 2, 2024, researcher Hirotaka Matsui, from the National Cancer Center Hospital in Tokyo, Japan, and Kumamoto University, published a new editorial paper in Oncotarget's Volume 15, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.” “[...] myeloid neoplasms associated with DDX41 variants likely exhibit a unique pathogenesis that diverges from the conventional understanding of myeloid neoplasms.” #PressRelease: https://lnkd.in/eXmD8UTQ #cancerresearch #AML #leukemia #neoplasms #openaccess #openscience #peerreviewed #journal #publication #publishing #meded
DDX41's Unique Contribution to Myeloid Leukemogenesis | Oncotarget
oncotarget.com
-
Watch video interviews from outstanding Oncotarget authors: https://lnkd.in/g2NXmc4M
Interviews with Outstanding Authors | Oncotarget
oncotarget.com
-
NEW #PaperoftheDay: "INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death" DOI ⬇️ https://lnkd.in/eppSDh2t
INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune...
oncotarget.com
-
Read Oncotarget’s 2023 publications in Volume 14: https://lnkd.in/dNnfbg7k #openaccess #publishing #journal #peerreviewed #publication #openscience #oncology #cancer #research #researchpapers #meded
Volume 14 (2023) | Oncotarget
oncotarget.com
-
Visit www.Oncotarget.net for interviews from distinguished Oncotarget authors. #openaccess #peerreviewed #oncology #cancer #researchpapers #science #medicine #medEd #OA
Oncotarget | Oncotarget.net
https://www.oncotarget.net
-
Oncotarget recently #published this #researchpaper in Volume 15, entitled, “G-quadruplex landscape and its regulation revealed by a new antibody capture method." https://lnkd.in/e_fMADmp #cancer #antibody #research #oncologyresearch #oncology #spotlight #trending #openaccess #openscience #peerreview #journal #publication #research #publishing #meded #oncotargetshort #video
-
Visit the Oncotarget archive, containing papers published from 2010-2024: https://lnkd.in/eviBde97
Archived Issues of Oncotarget | Oncotarget
oncotarget.com